The DeBio Network and KILT Protocol have officially announced their partnership today. As a result, this partnership will enable both networks to share their technologies. To be specific, KILT would integrate its credential into DeBio’s anonymous-first platform for medical and bioinformatics data.
In other words, KILT would serve as the underlying accreditation infrastructure, enabling labs and biomedical facilities to embed credentials on medical test results, genome sequences, and inter-lab collaborations.
On the other hand, DeBio Network, a blockchain-based platform known as Degenics, is creating a decentralized platform. This decentralized platform will provide synergy between medical and bioinformatics organizations while guaranteeing user anonymity and sovereignty throughout the biomedical data pipeline. Indeed, a great technology that really benefits the platform’s users.
Furthermore, to provide an additional layer of security, DeBio Network added a technology that focuses on privacy computing RnD, which maximizes user and data privacy. In fact, the network also aims to partner with Polkadot this year to strengthen its network security and expand its reach in the Polkadot ecosystem.
The initiator of DeBio Network, Pandu Sastrowardoyo, added:
DeBio is designed to prevent genetic data misuse, privacy and security violations, and the practice of selling genetic data without consent. We are implementing transformative technologies – Substrate’s blockchain framework, KILT’s identity protocol, and IPFS’s decentralized storage – to fulfill this mission.
Meanwhile, KILT, the blockchain protocol that enables innovative, industry-agnostic business models around identity, also intends to provide DeBio with a mechanism for issuing revocable, verifiable credentials that ensure privacy and data security.
Ingo Rübe, the founder of KILT Protocol, further explained:
In building an anonymous-first platform, DeBio Network is transforming medical interactions for consumers – truly a Web3 approach, which is essential for driving the digitization of the healthcare sector.
Ingo added that they aim to enable users to have full control over their health data. “Incorporating verifiable credentials through KILT provides users the anonymity needed for such personal data, adding a trust layer that gives users control over their health information.” He said.
Moreover, DeBio / Degenics won the Best IPFS Use for Identity award in February 2021 at the blockchain conference in Denver. More so, the network also took home the award for the United Nations Sustainable Development Goals (SDG). Truly, DeBio is a network that has proven to be great in its field of specialty using blockchain technology.
About DeBio Network
DeBio is an anonymous-first, decentralized platform for medical and bioinformatics data. We are building a decentralized platform for your personal medical needs, starting with genetics. Our concept allows synergy between labs of all scales while guaranteeing user anonymity and sovereignty at every step of the genomic data science workflow – from sample collection, data storage to report generation.
About KILT Protocol
- CMS Selects Stratis to Join equIP Accelerator Program
- Crypto.com Sponsors Italian Soccer For Coppa Italia Final
- Argentines Jump to BTC Amid Inflation and Economic Crisis
- Moma Protocol Successfully Completes $2.25M Funding Round